Skip to content

CDR

NACDS stresses ‘total’ in Total Store Expo

NACDS stresses ‘total’ in Total Store Expo

 The National Association of Chain Drug Stores is emphasizing the “Total” in its centerpiece Total Store Expo conference and trade show as it gets prospective attendees thinking about the 2018 event.

CVS-Aetna augurs new health care experience

CVS-Aetna augurs new health care experience

The pending $69 billion acquisition of Aetna by CVS could yield valuable lessons for others in the health care and drugstore sectors as they seek to forge stronger ties to consumers.

WBA scales back stake in China joint venture

WBA scales back stake in China joint venture

Walgreens Boots Alliance (WBA) plans to reduce its interest in Guangzhou Pharmaceuticals Corp., a pharmaceutical wholesale joint venture in China. WBA said Friday that, under the agreement, it will sell a 30% stake in Guangzhou Pharmaceuticals to Guangzhou Baiyunshan Pharmaceutical Holdings.

Lannett names Timothy Crew as CEO

Lannett names Timothy Crew as CEO

Timothy Crew, former chief executive officer of Cipla North America, is joining Lannett Co. as CEO. Plans call for Crew to take the CEO reins at effective Jan. 2, Lannett said. He also is slated to be appointed as a board director after the company’s 2018 annual shareholders meeting.

Allergan COO to become Amneal CEO

Allergan COO to become Amneal CEO

Merger partners Amneal Pharmaceuticals LLC and Impax Laboratories Inc. have tabbed Robert Stewart, executive vice president and chief operating officer of Allergan plc, to lead the combined company. Plans call for Stewart to join Amneal as president effective Jan. 25.

Campbell plans to buy Snyder’s-Lance for $4.9 billion

Campbell plans to buy Snyder’s-Lance for $4.9 billion

Campbell Soup Co. has agreed to acquire snack maker Snyder’s-Lance in a deal valued at about $4.9 billion. Campbell said the $50-per-share agreement will further its efforts to grow its snack product portfolio, notably better-for-you snacking options.

Bausch+Lomb releases Vyzulta

Bausch+Lomb releases Vyzulta

Bausch+Lomb has begun rolling out Vyzulta (latanoprostene bunod ophthalmic solution 0.024%) to U.S. pharmaceutical distributors. The Valeant Pharmaceuticals International subsidiary said Vyzulta is slated to become available to patients at pharmacies across the United States in the next few days.

P&G names Jimenez, Peltz to board after proxy fight

P&G names Jimenez, Peltz to board after proxy fight

After a lengthy proxy battle, Procter & Gamble Co. has named Novartis chief executive officer Joseph Jimenez and activist investor Nelson Peltz as directors. Jimenez and Peltz, co-founder of Trian Fund Management, are slated to join the board on March 1.

Unilever unveils Love Beauty and Planet brand

Unilever unveils Love Beauty and Planet brand

Unilever has launched Love Beauty and Planet, a hair and skin care brand focused on eco-friendliness and sustainability, ranging from ingredients and formulas to product packaging, value chain and social partnerships.